Top 7 Pharma Industry Leaders in 2020 By the Numbers
Delveinsight
AUGUST 25, 2021
Apart from these, Xarelto (for PAD) and Darzalex (for Amyloidosis and Refractory Multiple Myeloma) are in Phase III of clinical trials, while Tremfya (for Crohn’s Disease), Seltorexant (for insomnia), and Ciltacabtagene Autoleucei (BCMA CAR-T) (for multiple myeloma) are in Phase II of development. Merck and Company. billion), 0.3% (1.5
Let's personalize your content